Glimiwin MV2 Tablet
By Glimiwin MV
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - Docwin Healthcare
305/A, Panlee Complex, Mithakhali Cross Roads, Navrangpura, Ahmedabad - 380006

Expires on or after
December, 2025

liver
When using Glimiwin MV2 Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dosage accordingly, so it's best to consult with them before starting this medication. Typically, Rozmet Trio is initiated at a low dose for individuals with mild to moderate liver issues. However, it is not advisable to use this tablet if you have severe liver disease. If you have any concerns or liver-related issues, it's crucial to seek guidance from your healthcare provider before taking Glimiwin MV2 Tablet.

kidney
Glimiwin MV2 Tablet should be avoided if you have kidney disease. Consult your doctor before use. Not recommended for severe kidney disease.

alcohol
Avoid consuming alcohol while taking Glimiwin MV2 Tablet.

driving
Avoid driving if you experience symptoms of low or high blood sugar while taking Glimiwin MV2 Tablet, as it may affect your ability to drive safely.

pregnancy
Glimiwin MV2 Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess risks versus benefits before prescribing. Consult your doctor before use.

breastfeeding
Glimiwin MV2 Tablet is likely unsafe while breastfeeding. Limited data indicates the drug can pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹71.91
₹79.9
10% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024